Skip to content
Screener

BridgeBio Pharma BBIO Total Operating Expenses

Discontinued — last reported Q1 '21

Total Operating Expenses at other companies

Celcuity logo
CelcuityCELC
$50.51M+39.8%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$505.13M+90.8%
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$27.27M+2.8%
Tyra Biosciences, Inc. logo
Tyra Biosciences, Inc.TYRA
$42M+31.9%
Arrowhead Research logo
Arrowhead ResearchARWR
$215M+33.1%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$218.78M+64.8%

Other financials

Income statement

See full
Revenue$194.5M+66.8%
Gross profit$184.6M+61.9%
Operating income-$106.0M-1.5%
Net income-$166.6M+1.8%
EPS (diluted)-$0.84+4.5%

Balance sheet

See full
Cash & equivalents$882.0M+62.5%
Total debt$3.3B+32,101%
Total equity-$2.3B-38.2%
Total assets$1.4B+55.5%

Cash flow

See full
Operating cash flow-$197.3M+1.0%
CapEx$69.0K
Free cash flow-$197.3M+0.9%

Valuation

See full
Market cap$16.06B+87.5%
Enterprise value$18.44B+136%
P/S27.7×-8.6×

Profitability

See full
Gross margin95.1%-0.2pp
Operating margin-90.5%-41.2pp
Net margin-125.9%-54.5pp
FCF margin-76.8%

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio1.5×-3.0×

Where this comes from

Reported directly by BridgeBio Pharma in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: BridgeBio Pharma’s 10-Q, filed May 6, 2021. Open the filing →

Filed
May 6, 2021, 4:38 PM EDT
Fiscal quarter
Q1 FY2021
Calendar quarter
Q1 2021
Accession
0001564590-21-025064

FAQ

What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.